C. diff especially deadly for those with kidney disease, researchers find

Share this article:

People with end-stage renal disease (ESRD) have a significantly elevated risk of dying from Clostridium difficile infection, according to a recent study.

Researchers at Albert Einstein School of Medicine's Jacobi Medical Center in New York City compared outcomes of 104 ESRD patients on dialysis with a 300-person control group. They found those in the ESRD group had a C. diff-related mortality rate of 3.8%, while the other group's rate was 1.46%. ESRD patients were also more likely to have a relapse of severe C. diff infection within two months.

Combinining metronidazole and oral or rectal vancomycin was more effective than monotherapy drug treatment for the ESRD patients with C. diff, the researchers said. The monotherapy was associated with increased chances of a relapse, they found.

The research was released at the National Kidney Foundation 2013 Spring Clinical Meetings, held last week in Orlando, FL.

Share this article:

More in News

Nursing home antipsychotic use has dipped nearly 19% under national effort, latest figures show

Nursing home antipsychotic use has dipped nearly 19% ...

The percent of long-stay nursing home residents receiving antipsychotic medication has decreased 18.8% under a nationwide initiative that started in 2012.

Jimmo succeeds in getting Medicare coverage, two years after landmark case ended

Glenda Jimmo has reached a settlement with the federal government and will finally receive Medicare coverage for claims that were denied in 2007, which led her to file a class-action lawsuit over the so-called "improvement standard."

Breier named new CEO at Kindred

Breier named new CEO at Kindred

Kindred Healthcare announced Thursday that it has chosen a new top executive to lead its push toward creating a mammoth national brand. Benjamin A. Breier, the company's current president and ...